HCA Healthcare (HCA) Stock Forecast & Price Target

Compare

1,745 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HCA Analyst Ratings

Moderate Buy

13 Buy

5 Hold

1 Sell

Based on 19 analysts giving stock ratings to

HCA

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$482.17

▲(2.19% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $482.17 with a high forecast of $525.00 and a low forecast of $417.00. The average price target represents a 2.19% change from the last price of $471.85.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"296":"$296","411":"$411","526":"$526","353.5":"$353.5","468.5":"$468.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":525,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$525.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":482.17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$482.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":417,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$417.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[296,353.5,411,468.5,526],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,502.25,504,505.75,507.5,509.25,511,512.75,514.5,516.25,518,519.75,521.5,523.25,{"y":525,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,502.25,500.7053846153846,499.16076923076923,497.61615384615385,496.07153846153847,494.5269230769231,492.9823076923077,491.4376923076923,489.89307692307693,488.34846153846155,486.80384615384617,485.2592307692308,483.7146153846154,{"y":482.17,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,502.25,495.6923076923077,489.13461538461536,482.5769230769231,476.0192307692308,469.46153846153845,462.90384615384613,456.34615384615387,449.78846153846155,443.2307692307692,436.6730769230769,430.11538461538464,423.5576923076923,{"y":417,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":324.5,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.92,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.45,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":304.02,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.93,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":341.26,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":380.17,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.26,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":404.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":425.44,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":459,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":502.25,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$525.00

Average Price Target$482.17

Lowest Price Target$417.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ann Hynes

Mizuho Securities

$505→$520

Buy

10.20%

Upside

Reiterated

12/18/25

HCA Healthcare price target raised to $520 from $505 at MizuhoHCA Healthcare price target raised to $520 from $505 at Mizuho

Craig Hettenbach

Morgan Stanley

$425

Sell

-9.93%

Downside

Downgraded

12/15/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: BillionToOne, Inc. Class A (NASDAQ: BLLN), HCA Healthcare (NYSE: HCA) and Sanofi (Other OTC: SNYNF)

Stephen Baxter

Wells Fargo

$412→$431

Hold

-8.66%

Downside

Reiterated

11/12/25

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA), Avidity Biosciences (NASDAQ: RNA) and Cross Country Healthcare (NASDAQ: CCRN)

Benjamin Rossi

J.P. Morgan

$420

Hold

-10.99%

Downside

Reiterated

11/05/25

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Qiagen (NYSE: QGEN) and HCA Healthcare (NYSE: HCA)

Brian Tanquilut

Jefferies

$485→$525

Buy

11.26%

Upside

Reiterated

10/28/25

HCA Healthcare price target raised to $525 from $485 at JefferiesHCA Healthcare price target raised to $525 from $485 at Jefferies

David S Macdonald

Truist Financial

$460→$495

Buy

4.91%

Upside

Reiterated

10/27/25

Truist Financial Keeps Their Buy Rating on HCA Healthcare (HCA)

Michael Wiederhorn

Oppenheimer

$400→$500

Buy

5.97%

Upside

Reiterated

10/27/25

HCA Healthcare price target raised to $500 from $400 at OppenheimerHCA Healthcare price target raised to $500 from $400 at Oppenheimer

A.J. Rice

UBS

$495→$525

Buy

11.26%

Upside

Reiterated

10/27/25

HCA Healthcare price target raised to $525 from $495 at UBSHCA Healthcare price target raised to $525 from $495 at UBS

Scott Fidel

Goldman Sachs

$470→$520

Buy

10.20%

Upside

Reiterated

10/27/25

Goldman Sachs Sticks to Their Buy Rating for HCA Healthcare (HCA)

Sarah James

Cantor Fitzgerald

$444→$525

Buy

11.26%

Upside

Reiterated

10/27/25

HCA Healthcare price target raised to $525 from $444 at Cantor FitzgeraldHCA Healthcare price target raised to $525 from $444 at Cantor Fitzgerald

Ben Hendrix

RBC Capital

$449→$482

Buy

2.15%

Upside

Reiterated

10/27/25

RBC Capital Sticks to Its Buy Rating for HCA Healthcare (HCA)

Raj Kumar CFA

Stephens

$500

Buy

5.97%

Upside

Reiterated

10/27/25

HCA Healthcare (HCA) Gets a Buy from Stephens

Andrew Mok CFA

Barclays

$445→$494

Buy

4.69%

Upside

Reiterated

10/27/25

HCA Healthcare (HCA) Gets a Buy from Barclays

Matthew Gillmor CFA

KeyBanc

$465→$475

Buy

0.67%

Upside

Reiterated

10/27/25

KeyBanc Remains a Buy on HCA Healthcare (HCA)

Jason Cassorla

Guggenheim

Hold

―

Reiterated

10/27/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (NYSE: HCA), Revvity (NYSE: RVTY) and ANI Pharmaceuticals (NASDAQ: ANIP)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ann Hynes

Mizuho Securities

$505→$520

Buy

10.20%

Upside

Reiterated

12/18/25

HCA Healthcare price target raised to $520 from $505 at MizuhoHCA Healthcare price target raised to $520 from $505 at Mizuho

Craig Hettenbach

Morgan Stanley

$425

Sell

-9.93%

Downside

Downgraded

12/15/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: BillionToOne, Inc. Class A (NASDAQ: BLLN), HCA Healthcare (NYSE: HCA) and Sanofi (Other OTC: SNYNF)

Stephen Baxter

Wells Fargo

$412→$431

Hold

-8.66%

Downside

Reiterated

11/12/25

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA), Avidity Biosciences (NASDAQ: RNA) and Cross Country Healthcare (NASDAQ: CCRN)

Benjamin Rossi

J.P. Morgan

$420

Hold

-10.99%

Downside

Reiterated

11/05/25

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Qiagen (NYSE: QGEN) and HCA Healthcare (NYSE: HCA)

Brian Tanquilut

Jefferies

$485→$525

Buy

11.26%

Upside

Reiterated

10/28/25

HCA Healthcare price target raised to $525 from $485 at JefferiesHCA Healthcare price target raised to $525 from $485 at Jefferies

David S Macdonald

Truist Financial

$460→$495

Buy

4.91%

Upside

Reiterated

10/27/25

Truist Financial Keeps Their Buy Rating on HCA Healthcare (HCA)

Michael Wiederhorn

Oppenheimer

$400→$500

Buy

5.97%

Upside

Reiterated

10/27/25

HCA Healthcare price target raised to $500 from $400 at OppenheimerHCA Healthcare price target raised to $500 from $400 at Oppenheimer

A.J. Rice

UBS

$495→$525

Buy

11.26%

Upside

Reiterated

10/27/25

HCA Healthcare price target raised to $525 from $495 at UBSHCA Healthcare price target raised to $525 from $495 at UBS

Scott Fidel

Goldman Sachs

$470→$520

Buy

10.20%

Upside

Reiterated

10/27/25

Goldman Sachs Sticks to Their Buy Rating for HCA Healthcare (HCA)

Sarah James

Cantor Fitzgerald

$444→$525

Buy

11.26%

Upside

Reiterated

10/27/25

HCA Healthcare price target raised to $525 from $444 at Cantor FitzgeraldHCA Healthcare price target raised to $525 from $444 at Cantor Fitzgerald

Ben Hendrix

RBC Capital

$449→$482

Buy

2.15%

Upside

Reiterated

10/27/25

RBC Capital Sticks to Its Buy Rating for HCA Healthcare (HCA)

Raj Kumar CFA

Stephens

$500

Buy

5.97%

Upside

Reiterated

10/27/25

HCA Healthcare (HCA) Gets a Buy from Stephens

Andrew Mok CFA

Barclays

$445→$494

Buy

4.69%

Upside

Reiterated

10/27/25

HCA Healthcare (HCA) Gets a Buy from Barclays

Matthew Gillmor CFA

KeyBanc

$465→$475

Buy

0.67%

Upside

Reiterated

10/27/25

KeyBanc Remains a Buy on HCA Healthcare (HCA)

Jason Cassorla

Guggenheim

Hold

―

Reiterated

10/27/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (NYSE: HCA), Revvity (NYSE: RVTY) and ANI Pharmaceuticals (NASDAQ: ANIP)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

1 Month

xxx

Success Rate

27/38 ratings generated profit

Average Return

+4.91%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 71.05% of your transactions generating a profit, with an average return of +4.91% per trade.

3 Months

xxx

Success Rate

23/30 ratings generated profit

Average Return

+9.88%

reiterated a xxx

rating yesterday

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 76.67% of your transactions generating a profit, with an average return of +9.88% per trade.

1 Year

Ben HendrixRBC Capital

Success Rate

23/23 ratings generated profit

Average Return

+28.62%

reiterated a buy rating 2 months ago

Copying Ben Hendrix's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +28.62% per trade.

2 Years

xxx

Success Rate

46/46 ratings generated profit

Average Return

+55.06%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +55.06% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HCA has received 25 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. HCA average Analyst price target in the past 3 months is 482.17.

Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $7.45 with a range of $7.11 to $7.71. The previous quarter’s EPS was $6.96. HCA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $19.67B with a range of $19.26B to $20.05B. The previous quarter’s sales results were $19.16B. HCA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?

Based on analyst ratings, HCA Healthcare’s 12-month average price target is 482.17.

What is HCA’s upside potential, based on the analysts’ average price target?

HCA Healthcare has 2.19% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HCA a Buy, Sell or Hold?

HCA Healthcare has a consensus rating of Moderate Buy which is based on 13 buy ratings, 5 hold ratings and 1 sell ratings.

What is HCA Healthcare’s price target?

The average price target for HCA Healthcare is 482.17. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $525.00 ,the lowest forecast is $417.00. The average price target represents 2.19% Increase from the current price of $471.85.

What do analysts say about HCA Healthcare?

HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of HCA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Analyst Ratings

HCA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HCA Healthcare

HCA Analyst Recommendation Trends

HCA Financial Forecast

HCA Earnings Forecast

HCA Sales Forecast

HCA Stock Forecast FAQ

Detailed List of Analyst Forecasts